Civic Intelligence

Immunotherapy Foundation

990 • Fiscal year 2015 • EIN 47-3847309

Jan 01, 2015 to Dec 31, 2015

San Diego, CA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

13th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2015 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2015

Liabilities / Revenue

13th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2015 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2015

Net Margin

89th percentile

40%

Higher net margin than 89% of similar nonprofits.

2015 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2015

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2015

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2015

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2015

Assets

$1,829,474

No earlier filing loaded for comparison.

Net Assets

$1,829,474

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

$4,604,110

No earlier filing loaded for comparison.

Expenses

$2,774,636

No earlier filing loaded for comparison.

Net Income

$1,829,474

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$2.0M$1.5M$1.0M$500K$0Assets 2015: $1,829,474Liabilities 2015: $0Net Assets 2015: $1,829,4742015Assets 2016: $1,367,985Liabilities 2016: $0Net Assets 2016: $1,367,9852016Assets 2017: $1,195,424Liabilities 2017: $9,656Net Assets 2017: $1,185,7682017Assets 2018: $877,650Liabilities 2018: $9,883Net Assets 2018: $867,7672018Assets 2019: $446,267Liabilities 2019: $10,903Net Assets 2019: $435,3642019Assets 2020: $1,084,640Liabilities 2020: $532,160Net Assets 2020: $552,4802020Assets 2021: $309,684Liabilities 2021: $5,131Net Assets 2021: $304,5532021

Highlighted filing

2015

Assets$1,829,474
Liabilities$0
Net Assets$1,829,474

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$6.0M$4.0M$2.0M$0-$2.0MRevenue 2015: $4,604,110Expenses 2015: $2,774,636Net Income 2015: $1,829,4742015Revenue 2016: $835,439Expenses 2016: $1,296,928Net Income 2016: -$461,4892016Revenue 2017: $267,707Expenses 2017: $449,924Net Income 2017: -$182,2172017Revenue 2018: $483,908Expenses 2018: $817,470Net Income 2018: -$333,5622018Revenue 2019: $832,651Expenses 2019: $1,265,054Net Income 2019: -$432,4032019Revenue 2020: $1,650,667Expenses 2020: $1,533,551Net Income 2020: $117,1162020Revenue 2021: $92,766Expenses 2021: $340,693Net Income 2021: -$247,9272021

Highlighted filing

2015

Revenue$4,604,110
Expenses$2,774,636
Net Income$1,829,474
Filing Detail Status

This 2015 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2015 to Dec 31, 2015
Mission and Program Overview

Mission

Immunotherapy Foundations (IF) initial mission is to find an effective treatment, and ultimately a cure for HPV-related cancers through the partnering and funding of research, studies and revolutionary treatments broadly known as immunotherapy. This research falls under the following three broad immunotherapy categories: adoptive cell therapies, immune response vaccines, and novel drugs.All projects will be designed to bring promising human therapies to the clinic. The projects will address the biology of HPV-related cancers, particularly those of the head and neck. The current research shows promise to extend to other malignancies. The projects are tightly interconnected to leverage information, allowing efficient movement into the clinic.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings